- Monte Rosa Therapeutics (NASDAQ:GLUE): Q3 GAAP EPS of -$0.43 beats by $0.03.
- Cash and cash equivalents as of Sept. 30, 2021, were $367.0 million.
- Press Release
Monte Rosa Therapeutics EPS beats by $0.03
Recommended For You
More Trending News
About GLUE Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
GLUE | - | - |
Monte Rosa Therapeutics, Inc. |